AP
Wal-Mart
Expands $4 Drugs Program
Thursday September 27, 10:03 am ET
By Marcus Kabel, AP Business Writer
Wal-Mart Stores Add More Drugs to Its $4 Generic Prescription Program
Wal-Mart Stores Inc. is expanding its national $4 generic prescription
drug program by about 10 percent, adding drugs for some new conditions.
The world's largest retailer said Thursday it has added drugs covering
glaucoma, attention deficit disorder, attention deficit hyperactivity
disorder, fungal infections and acne.
Two prescription birth control drugs and one fertility drug were
added at $9, reflecting a higher cost that the company said could
not be brought down further.
The Bentonville, Ark.-based retailer launched the
$4 generics program late last year as it pushed a variety of health
and environmental initiatives to counter political pressure led
by union groups over its labor practices, including health insurance.
"We have taken what we do best, working with
suppliers, driving costs out of the supply chain and passing those
savings to our customers. Now we're applying that to health care,"
chief operating officer Bill Simon said on a conference call for
reporters and analysts.
The increase adds about 30 prescriptions, made up
of 14 drugs in various doses, to a list of 331 prescriptions and
143 drug compounds sold under the first phase introduced last year.
Critics including the National Community Pharmacists
Association, which represents non-chain pharmacies that compete
with Wal-Mart, have called the discounts a publicity stunt that
covers only a fraction of the 8,700 generic prescription drugs approved
by the Federal Drug Administration.
Analysts have said the main benefit for Wal-Mart
was in drawing more shoppers into its stores who may come for prescriptions
and then make purchases in other departments.
Wal-Mart has made the $4 plan, which covers 30 days
worth of generic drugs, a central plank of its public relations
effort and says the program has cut over $610 million in health
care costs since it started. That figure is the difference between
the old price it charged for the generics and the new price, times
the number of prescriptions sold, Simon said.
Simon said Wal-Mart is not selling any of the $4
prescriptions at a loss. The generics are profitable, he said, without
providing detailed figures.
Simon said the $4 generics under the first phase
account for just under 40 percent of all prescriptions filled at
Wal-Mart pharmacies. He projected that rate will climb to well over
40 percent with the new drugs.
|